任婕,彭芝兰
REN Jie,PENG Zhilan

• 1:贵阳医学院附院妇产科
• 2:四川大学华西第二医院妇产科

摘要(Abstract)：

目的:检测上皮性卵巢癌、卵巢交界性肿瘤及正常卵巢组织中细胞周期蛋白依赖性激酶2(P34cdc2激酶)的表达,探讨其与临床病理因素之间的关系。方法:采用免疫组织化学SP法检测30例上皮性卵巢癌、14例交界性肿瘤及20例正常卵巢组织中P34cdc2激酶的表达,应用BioMias图像分析系统计算阳性指数(positive index,PI)并结合临床资料,分析P34cdc2激酶与各临床病理因素的关系。结果:P34cdc2激酶在正常卵巢组织、卵巢交界性肿瘤及上皮性卵巢癌组织中的PI呈递增趋势,每两组间比较差异有统计学意义;P34cdc2在分期晚、组织分化差或伴有淋巴结转移时表达强度高,差异有统计学意义(P<0.05);在不同年龄组、不同病理类型间的P34cdc2激酶表达差异无统计学意义(P>0.05)。结论:P34cdc2激酶过度表达可能促进上皮性卵巢癌的发生、发展,高表达可能提示预后不良。
Objective: To detect the expression of cyclin dependent kinase 2( P34cdc2) in epithelial ovarian carcinoma,borderline ovarian tumor and normal ovarian tissues,and to explore its relationship with clinical and pathological factors. Methods: The expression of P34cdc2protein in 30 cases of epithelial ovarian carcinoma,14 cases of borderline ovarian tumor and 20 cases of normal ovarian tissues were detected by using immunohistochemistry SP method. BioMias image analysis system was used to calculate the positive index( PI). The relationship between P34cdc2expression and clinical pathological factors of ovarian cancer was analyzed. Results: PI showed an increasing trend from epithelial ovarian carcinoma,borderline ovarian tumor to normal ovarian tissues,and the differences between any two groups were significant. In epithelial ovarian carcinoma,the expression of P34cdc2was intensive in patients in late stages,with poor tumor cell differentiation and lymphnode metastasis( P < 0. 05). The expression of P34cdc2was not related to age and pathological types( P > 0. 05). Conclusions: P34cdc2 excessive expression may promote the occurrence and development of epithelial ovarian carcinoma. Its high expression may indicate poor prognosis.

关键词(KeyWords)： 癌;卵巢;细胞周期蛋白依赖性激酶2;细胞周期;预后
carcinoma;ovary;cyclin dependent kinase 2;cell cycle;prognosis

Abstract:

Keywords:

基金项目(Foundation): 贵州省科技厅资助项目(项目编号:E2009-39)

作者(Author): 任婕,彭芝兰
REN Jie,PENG Zhilan

DOI: 10.19367/j.cnki.1000-2707.2014.02.008

参考文献(References)：

• [1]吕有勇.从生物多样性和基因多态性认识肿瘤生物学行为及基因改变的异质性[J].世界华人消化杂志,2002(6):690-692.
• [2]刘晓红,易亮,陈冷昕,等.雌激素对人乳腺癌细胞周期蛋白E表达及血清饥饿时细胞存活力的影响[J].贵阳医学院学报,2011(6):551-553.
• [3]蔡扬,柳咏发,李世灵,等.口腔鳞状细胞癌细胞周期蛋白E表达与中心体扩增相关性[J].贵阳医学院学报,2007(6):375-378.
• [4]Chae SW,Sohn JH,Kim DH,et al.Overexpressions of Cyclin B1,cdc2,p16 and p53 in human breast cancer:the clinicopathologic correlations and prognostic implications[J].Yonsei Med J,2011(3):445-453.
• [5]Kim S,Lee HS,Lee SK,et al.12-O-Tetradecanoyl phorbol-13-acetate(TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells[J].Am J Surg Pathol,2010(14):1127-1132.
• [6]马沛卿,薛丽燕,谢永强,等.CDC2在食管鳞状细胞癌及癌前病变中的表达与临床意义[J].中国肿瘤临床与康复,2011(2):102-105.
• [7]Prat J.Staging classification for cancer of the ovary,fallopian tube,and peritoneum[J].Int J Gynecol Obstet,2014(1):1-5.
• [8]韩淑霞.卵巢癌的放射治疗[J].中华健康文摘,2011(5):183-184.
• [9]Kase S,Yoshida K,Ohgami K,et al.Expression of cdc2and p27(KIP1)phosphorylation in mitotic cells of the human retinoblastoma[J].Int J Mol Med,2006(3):465-468.
• [10]Kim SJ,Nakayama S,Miyoshi Y,et al.Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer[J].Ann Oncol,2008(1):68-72.
• [11]Senju M,Sueoka N,Sato A,et al.Hsp90 inhibitors cause G2/M arrest associated with the reduction of CDC25C and Cdc2 in lung cancer cell lines[J].J Cancer Res Clin Oncol,2006(3):150-158.
• [12]Kim DH.Prognostic implications of cyclin B1,p34cdc2,p27(Kip1)and p53 expression in gastric cancer[J].Yonsei Med J,2007(4):694-700.
• [13]李波,阙祥勇,李意,等.cdc2基因在多种人类肿瘤细胞中的表达及意义[J].广东医学,2012(14):2035-2037.

文章评论(Comment)：